This chemical is primarily used as a chiral ligand in asymmetric catalysis, particularly in transition metal-catalyzed reactions. It is highly effective in facilitating enantioselective transformations, such as hydrogenation, carbon-carbon bond formation, and other asymmetric syntheses. Its unique structure, featuring ferrocene and bulky trifluoromethyl groups, provides excellent steric and electronic properties, enhancing selectivity and efficiency in producing chiral molecules. It is widely applied in the pharmaceutical industry for the synthesis of enantiomerically pure drugs and fine chemicals. Additionally, it is utilized in academic research to develop new catalytic methodologies and explore asymmetric synthesis pathways.